Literature DB >> 28277119

Brain-derived neurotrophic factor (BDNF) plasma concentration in patients diagnosed with premature ovarian insufficiency (POI).

Adam Czyzyk1, Dorota Filipowicz2, Agnieszka Podfigurna1, Paula Ptas2, Malgorzata Piestrzynska2, Roman Smolarczyk3, Andrea R Genazzani4, Blazej Meczekalski1.   

Abstract

Premature ovarian insufficiency (POI) is defined as a cessation of function of ovaries in women younger than 40 years old. Brain-derived neurotrophic factor (BDNF) is a protein critically involved in neuronal growth and metabolism. BDNF also has been shown to be important regulator of oocyte maturation. Recent data show that BDNF can be potentially involved in POI pathology. The aim of the study was to assess the BDNF plasma concentrations in patients diagnosed with idiopathic POI. 23 women diagnosed with POI (age 31 ± 7 years) and 18 (age 31 ± 3) controls were included to the study, matched according to age and body mass index. The BDNF concentrations were measured using competitive enzyme-linked immunosorbent assay (ELISA). Hormonal and metabolic parameters were measured in all individuals, in controls in late follicular phase. The POI group demonstrated lower mean plasma concentrations of BDNF (429.25 ± 65.52 pg/ml) in comparison to healthy controls (479.75 ± 34.75 pg/ml, p = 0.0345). The BDNF plasma concentration correlated negatively (R = -0.79, p < 0.001) with number of months since last menstrual period. There was a positive correlation between BDNF and progesterone in controls. In conclusion, POI patients show significantly lower BDNF plasma concentration and it correlates with the duration of amenorrhea. This observation brings important potential insights to the pathology of POI.

Entities:  

Keywords:  Brain-derived neurotrophic factor; menopause; premature ovarian insufficiency

Mesh:

Substances:

Year:  2017        PMID: 28277119     DOI: 10.1080/09513590.2017.1290073

Source DB:  PubMed          Journal:  Gynecol Endocrinol        ISSN: 0951-3590            Impact factor:   2.260


  3 in total

1.  Dysregulated cytokine profile associated with biochemical premature ovarian insufficiency.

Authors:  Peihao Liu; Xiruo Zhang; Jingmei Hu; Linlin Cui; Shidou Zhao; Xue Jiao; Yingying Qin
Journal:  Am J Reprod Immunol       Date:  2020-06-26       Impact factor: 3.886

2.  TrkB agonist antibody ameliorates fertility deficits in aged and cyclophosphamide-induced premature ovarian failure model mice.

Authors:  Xunsi Qin; Yue Zhao; Tianyi Zhang; Chenghong Yin; Jie Qiao; Wei Guo; Bai Lu
Journal:  Nat Commun       Date:  2022-02-17       Impact factor: 17.694

Review 3.  Metabolic differences in women with premature ovarian insufficiency: a systematic review and meta-analysis.

Authors:  Wang-Yu Cai; Xi Luo; Wei Wu; Jianyuan Song; Ning-Ning Xie; Cuicui Duan; Xiao-Ke Wu; Jian Xu
Journal:  J Ovarian Res       Date:  2022-09-30       Impact factor: 5.506

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.